Buy The Dip And Ride The Rotation: 5 Top Growth And Income Stocks

The best growth and income stocks offer strong fundamentals, dividends, and diversification for today's volatile market.

Alliant Energy: No Longer The Time To Buy Now (Rating Downgrade)

Alliant Energy stock looks positioned to deliver high single-digit percentage annual total returns through 2031. Here's what ...
The Manila Times

InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small ...

InxMed Co., Ltd ('InxMed'), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical ...

Vanguard Long-Term Treasury ETF vs iShares Corporate Bond ETF: Which Bond Fund Offers the Best Combination of Safety and Investment Returns?

LQD outperformed VGLT by 32% over five years, but VGLT's ultra-low 0.03% expense ratio and government backing appeal to ...
The American Journal of Managed Care

SYNC-T: Immunotherapy Platform Brings 4-Part Attack in Prostate Cancer, With More Trials Planned

Development is moving to phase 2 LEGION-100-2a (NCT06533644) across global sites, with planned neoadjuvant prostate studies and expansion concepts in multiple solid tumors. Metastatic ...

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 ...
Just Baseball

Mets Midseason Report Card: Grading Every Player After 81 Games

As the 2026 MLB season officially reaches its halfway point, here are letter grades for every Mets player thus far.
The Manila Times

CHMP recommendation advances Johnson & Johnson’s TECVAYLI® (teclistamab) plus daratumumab as a potential standard of care for relapsed/refractory multiple myeloma

Recommendation supported by unprecedented Phase 3 data, demonstrating that TECVAYLI® in combination with daratumumab achieved statistically significant improvements in progression-free and overall ...
Las Vegas Sun

U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer

(Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy ® (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug conjugate (ADC), ...
The New York Times

NBA Draft 2026 results: Grades, analysis, fits for every first-round pick

Yaxel Lendeborg celebrates with his mother, Yissel Raposo, after being selected in the lottery by the Warriors. Arturo Holmes / Getty Images Day 1 of the 2026 NBA Draft is done, and The Athletic’s ...

European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors

(Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization for Trodelvy ® (sacituzumab govitecan-hziy) as monotherapy for the treatment of adult patients with ...